Related references
Note: Only part of the references are listed.Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Can machine-learning improve cardiovascular risk prediction using routine clinical data?
Stephen F. Weng et al.
PLOS ONE (2017)
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Mark R. Thomas et al.
CIRCULATION RESEARCH (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Massimo F. Piepoli et al.
ATHEROSCLEROSIS (2016)
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
Peter Willeit et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study
Andrea Ganna et al.
LANCET (2015)
Probabilistic machine learning and artificial intelligence
Zoubin Ghahramani
NATURE (2015)
Challenges of linking to routine healthcare records in UK Biobank
Ligia Adamska et al.
TRIALS (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Iciar Martin-Timon et al.
WORLD JOURNAL OF DIABETES (2014)
MissForest-non-parametric missing value imputation for mixed-type data
Daniel J. Stekhoven et al.
BIOINFORMATICS (2012)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comparisons of established risk prediction models for cardiovascular disease: systematic review
George C. M. Siontis et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
K. Eeg-Olofsson et al.
JOURNAL OF INTERNAL MEDICINE (2010)
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Philip Greenland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients
Hilal Maradit Kremers et al.
ARTHRITIS AND RHEUMATISM (2008)
Conditional variable importance for random forests
Carolin Strobl et al.
BMC BIOINFORMATICS (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life
Matthew A. Allison et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
Thomas A. Gaziano et al.
LANCET (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries
Shanthi Mendis et al.
JOURNAL OF HYPERTENSION (2007)
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
Ruth L. Coleman et al.
DIABETES CARE (2007)
Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse et al.
CIRCULATION (2007)
Trust and sources of health information - The impact of the Internet and its implications for health care providers: Findings from the first Health Information National Trends Survey
BW Hesse et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Evaluating the performance of the Framingham risk equations in a population with diabetes
P McEwan et al.
DIABETIC MEDICINE (2004)
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
L Sjöström et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
G Assmann et al.
CIRCULATION (2002)
Soft margins for AdaBoost
G Rätsch et al.
MACHINE LEARNING (2001)
Share Paper
